NASDAQ:BGLC BioNexus Gene Lab (BGLC) Stock Price, News & Analysis $0.49 -0.02 (-3.93%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.48▼$0.5350-Day Range$0.42▼$0.6052-Week Range$0.31▼$3.87Volume50,864 shsAverage Volume764,168 shsMarket Capitalization$8.65 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get BioNexus Gene Lab alerts: Email Address Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. About BioNexus Gene Lab Stock (NASDAQ:BGLC)BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Read More BGLC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BGLC Stock News HeadlinesJuly 18, 2024 | americanbankingnews.comBioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Significant Growth in Short InterestJuly 17, 2024 | americanbankingnews.comBioNexus Gene Lab (NASDAQ:BGLC) vs. Laboratory Co. of America (NYSE:LH) Financial ContrastJuly 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.April 19, 2024 | msn.comWhy Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionApril 19, 2024 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?April 18, 2024 | marketwatch.comBioNexus Gene Lab Invests in AI Healthcare CompanyApril 18, 2024 | globenewswire.comBioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareFebruary 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Short Interest ReportJuly 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.February 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Analyst Ratings, Price Targets, PredictionsFebruary 14, 2024 | finance.yahoo.comCompanies Like BioNexus Gene Lab (NASDAQ:BGLC) Can Afford To Invest In GrowthDecember 20, 2023 | nasdaq.comBioNexus Gene Lab Corp Common stock (BGLC)November 22, 2023 | seekingalpha.comBGLC BioNexus Gene Lab Corp.October 16, 2023 | sg.finance.yahoo.comBioNexus Gene Lab Corp. (BGLC)August 23, 2023 | markets.businessinsider.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 33% Today?July 28, 2023 | investing.comBioNexus Gene Lab Corp (BGLC)July 24, 2023 | seekingalpha.comIPO Roundup: Surf Air Mobility, Opti-Harvest and moreJuly 24, 2023 | finanznachrichten.deBIONEXUS GENE LAB CORPSee More Headlines Receive BGLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/26/2024Next Earnings (Estimated)8/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:BGLC CUSIPN/A CIK1737523 Webwww.bionexusgenelab.com Phone60-1-2212-6512FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,630,000.00 Net Margins-27.24% Pretax Margin-26.99% Return on Equity-30.74% Return on Assets-25.41% Debt Debt-to-Equity RatioN/A Current Ratio4.60 Quick Ratio3.98 Sales & Book Value Annual Sales$9.77 million Price / Sales0.88 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book0.89Miscellaneous Outstanding Shares17,670,000Free Float16,460,000Market Cap$8.65 million OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Su-Leng Tan (Age 40)CEO, Acting CFO, Secretary & Director Comp: $16kMr. Kwan Wah ChanMarketing ManagerMr. Too Kam ThamManaging DirectorKey CompetitorsExagenNASDAQ:XGNRenalytixNASDAQ:RNLXPsychemedicsNASDAQ:PMDOpGenNASDAQ:OPGNAclarionNASDAQ:ACONView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 20,888 shares on 5/20/2024Ownership: 0.266%View All Institutional Transactions BGLC Stock Analysis - Frequently Asked Questions How have BGLC shares performed this year? BioNexus Gene Lab's stock was trading at $0.53 at the beginning of the year. Since then, BGLC shares have decreased by 7.7% and is now trading at $0.4893. View the best growth stocks for 2024 here. How were BioNexus Gene Lab's earnings last quarter? BioNexus Gene Lab Corp. (NASDAQ:BGLC) released its quarterly earnings results on Wednesday, May, 15th. The company reported ($0.02) EPS for the quarter. The firm earned $2.38 million during the quarter. BioNexus Gene Lab had a negative net margin of 27.24% and a negative trailing twelve-month return on equity of 30.74%. When did BioNexus Gene Lab IPO? BioNexus Gene Lab (BGLC) raised $5 million in an initial public offering on Thursday, July 20th 2023. The company issued 1,300,000 shares at a price of $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO. How do I buy shares of BioNexus Gene Lab? Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BGLC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.